WO2020082345A1 - 通便保健组合物及其制备方法、通便保健茶 - Google Patents
通便保健组合物及其制备方法、通便保健茶 Download PDFInfo
- Publication number
- WO2020082345A1 WO2020082345A1 PCT/CN2018/112135 CN2018112135W WO2020082345A1 WO 2020082345 A1 WO2020082345 A1 WO 2020082345A1 CN 2018112135 W CN2018112135 W CN 2018112135W WO 2020082345 A1 WO2020082345 A1 WO 2020082345A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- jujube
- parts
- laxative
- laxative health
- licorice
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims description 15
- 235000015872 dietary supplement Nutrition 0.000 title abstract 3
- 230000001079 digestive effect Effects 0.000 title abstract 3
- 241001122767 Theaceae Species 0.000 title description 27
- 239000002994 raw material Substances 0.000 claims abstract description 43
- 238000002791 soaking Methods 0.000 claims abstract description 14
- 230000002475 laxative effect Effects 0.000 claims description 129
- 239000008141 laxative Substances 0.000 claims description 128
- 230000036541 health Effects 0.000 claims description 124
- 241001247821 Ziziphus Species 0.000 claims description 99
- 241000202807 Glycyrrhiza Species 0.000 claims description 52
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 52
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 52
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 52
- 229940010454 licorice Drugs 0.000 claims description 52
- 241000209140 Triticum Species 0.000 claims description 49
- 235000021307 Triticum Nutrition 0.000 claims description 49
- 241000208966 Polygala Species 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 30
- 238000005520 cutting process Methods 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 23
- 238000011282 treatment Methods 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 19
- 241001080798 Polygala tenuifolia Species 0.000 claims description 16
- 239000010017 yuan zhi Substances 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 8
- 229940100688 oral solution Drugs 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000003825 pressing Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims 4
- 238000012856 packing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 11
- 230000001914 calming effect Effects 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 5
- 230000029087 digestion Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 10
- 206010010774 Constipation Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000035622 drinking Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 206010065360 Anal prolapse Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- HGCRMXNQSAARKC-UHFFFAOYSA-N ethyl 2-methyl-4-propylpyrimidine-5-carboxylate Chemical compound CCCC1=NC(C)=NC=C1C(=O)OCC HGCRMXNQSAARKC-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000013370 mutualism Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Definitions
- the invention belongs to the technical field of health care tea, in particular to a laxative health care composition and a preparation method thereof, and a laxative health tea, a laxative health oral liquid and a laxative health tablet containing the laxative health care composition.
- Tea drinking culture has a history of thousands of years in China. Drinking tea has a long history of relaxing tension and preventing health care. "Tangmuzhang” records, "Ming, bitter tea, tea taste sweet and bitter, slightly cold and non-toxic, a main fistula, easy to urinate, phlegm, quench thirst, make people sleep less”.
- Constipation is a common and complicated symptom in clinic, usually manifested as: less bowel movements and fewer bowel movements; difficult and difficult bowel movements; poor bowel movements; dry, hard stools, and unclean bowel movements.
- Long-term constipation can be accompanied by symptoms such as abdominal distension, abdominal pain, and bloody stools, which can easily induce the onset of heart and cerebrovascular diseases, severe hemorrhoids, anal fissures, and prolapse of the anus.
- the embodiments of the present invention provide a laxative health care composition and a preparation method thereof, laxative health tea, laxative health oral liquid, and laxative health tablet, aiming to solve the problem that the existing existing health tea products are not clear, The problem of unsatisfactory efficacy.
- a laxative health care composition consisting of the following components in the following parts by weight:
- Sour jujube kernel 0.3 ⁇ 5 servings.
- a method for preparing laxative health tea includes the following steps:
- the treatment raw material is weighed according to the formula of the laxative health care composition of the present invention, and the treatment raw material is mixed and sterilized to obtain a laxative health care composition.
- a preparation method of laxative health tablets includes the following steps:
- the treatment raw materials are weighed, the treatment raw materials are uniformly mixed, and after sterilization treatment, they are directly compressed into tablets to obtain laxative health care tablets.
- a preparation method of laxative health oral liquid includes the following steps:
- the laxative health care composition of the present invention weigh licorice, wheat, jujube, polygala, and jujube kernels, mix the raw material components uniformly, add 130 ⁇ 170 parts of water, soak for 15-60 min, decoction the immersion liquid for 20-40min to concentrate the decoction liquid to 60-80 parts, and filter to obtain filter residue A and filtrate A;
- the filtrate A and the filtrate B are mixed evenly to obtain a laxative health oral solution.
- the laxative health oral liquid is obtained from the laxative health composition prepared by the method of the present invention, which is packaged and processed according to the specification of 3 g to 12 g per package.
- a laxative health care oral liquid which is obtained by dividing the oral liquid prepared by the method of the present invention into separate packages.
- a laxative health-care tablet The laxative health-care oral liquid is obtained by pressing and packaging the laxative health-care tablet according to the specification of 2g-6g per tablet.
- the laxative health care composition provided by the present invention is composed of a specific formula. Through reasonable formulation, the synergistic effect of each component is fully exerted. It has laxative, nourishing and calming mind, anti-fatigue, increases memory, helps sleep, beauty Fat removal effect. At the same time, the raw materials of the laxative health care composition do not need to be processed in depth, and can be soaked for use, which is simple and convenient. In addition, the laxative health care composition uses common traditional Chinese medicine ingredients as constituent materials, without adding expensive traditional Chinese medicine components or additives, and can effectively reduce the cost of the laxative health care composition while ensuring the above functions.
- the preparation method of the laxative health tea provided by the invention does not require deep processing, so the preparation process is simple, easy to produce, and the cost is low.
- the preparation method of the laxative health care oral liquid provided by the present invention, after the laxative health care composition is soaked with specific content of water in stages, the filtrates are combined and obtained without deep processing, so the preparation process is simple and easy to produce. low cost.
- the preparation method of the laxative health care oral liquid provided by the present invention is obtained by mixing the laxative health care composition and pressing it for processing, without further processing, so the preparation process is simple, easy to produce, and the cost is low.
- laxative health care composition of the present invention After the laxative health care composition of the present invention is made into laxative health tea, laxative health oral liquid and laxative health tablet, it can be more convenient for the user to take and improve the convenience of use.
- first and second are used for description purposes only, and cannot be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated.
- the features defined as “first” and “second” may explicitly or implicitly include one or more of the features.
- the meaning of “plurality” is two or more, unless otherwise specifically limited.
- An aspect of the embodiments of the present invention provides a laxative health care composition, which is composed of the following components in the following parts by weight:
- Sour jujube kernel 0.3 ⁇ 5 servings.
- the laxative health care composition provided by the embodiment of the present invention is composed of a specific formula, and through reasonable formulation, it fully exerts the synergistic effect of each component in it, and has the functions of laxative, nourishing the mind, calming the mind, resisting fatigue, increasing memory, and helping sleep , The effect of beauty fat removal.
- the raw materials of the laxative health care composition do not need to be processed in depth, and can be soaked for use, which is simple and convenient.
- the laxative health care composition uses common traditional Chinese medicine ingredients as constituent materials, without adding expensive traditional Chinese medicine components or additives, and can effectively reduce the cost of the laxative health care composition while ensuring the above functions.
- the laxative health care composition is composed of the following components in the following parts by weight:
- Sour jujube kernel 0.8 ⁇ 3 servings.
- licorice enters the lung meridian.
- the licorice contains various active ingredients, and has the functions of clearing away heat and detoxifying, replenishing qi and spleen, expelling phlegm and cough, nourishing cough and moistening lung, relieve pain and relieve pain, and reconcile various medicines.
- licorice can exert the effects of weak spleen and stomach, shortness of heart and palpitations, fatigue, fatigue, carbuncle and sore, as well as spleen and stomach qi, fatigue and fatigue.
- the licorice is used as a component of the laxative health care composition, which can inhibit the excessive secretion of gastric acid caused by histamine, and has the effect of acid resistance and relief of gastrointestinal smooth muscle spasm.
- the licorice is used as a component of the laxative health care composition, and the dosage is 0.2-5 parts, specifically 0.2 parts, 0.5 parts, 0.8 parts, 1.0 parts, 2.0 parts, 3.5 parts, 4.0 parts, 5.0 Copies.
- wheat enters the heart meridian.
- the wheat is rich in nutrients and contains starch, protein, sugar, fat, lecithin, arginine, maltose, protease, vitamins and other ingredients, which can not only provide heat to the body, but also increase cell vitality and adjust gastrointestinal function , Improve brain cell function, anti-aging, prevent cardiovascular and cerebrovascular diseases.
- Wheat as a traditional Chinese medicine component of the laxative health care composition described in the embodiments of the present invention can improve the laxation of patients with constipation.
- the licorice is used as a component of the laxative health care composition, and the dosage is 1 to 10 parts, which may specifically be 1, 2.5 parts, 4 parts, 4.5 parts, 6 parts, 6.5 parts, 8 parts, 9 parts 10 copies.
- the jujube enters the spleen.
- Jujube has the effects of strengthening the spleen and stomach, invigorating qi, nourishing the blood and calming the nerves. It can be used for spleen deficiency, less spleen and stomach, weak spleen and stomach, fatigue, loose stools, fatigue, insufficiency of qi and blood, insomnia, and dirty woman.
- Jujube has high dietary fiber content, which is mainly concentrated in the skin, which can effectively promote gastrointestinal peristalsis and improve the laxation of patients with constipation.
- jujube is rich in vitamin C and adenosine cyclic phosphate, which can promote the metabolism of skin cells, prevent melanin deposition, make the skin more and more white and smooth, and achieve the beauty skin care effect of whitening skin and freckles.
- Jujube has the functions of preventing blood transfusion reaction, lowering serum alanine aminotransferase, and a certain degree of anti-tumor, anti-oxidation, lowering blood pressure, lowering cholesterol, protecting liver, improving immunity, etc. It can be used to prevent and control cerebral insufficiency, anti-allergy, prevent heart Vascular disease, prevention of osteoporosis and anemia.
- the jujube is used as a component of the laxative health care composition, and the dosage is 4-8 parts, specifically 1, 3 parts, 3.3 parts, 4 parts, 5 parts, 5.5 parts, 6 parts, 7.5 copies, 8 copies, 10 copies, 11 copies.
- Yuanzhi enters the kidney meridian.
- the Yuanzhi contains more dietary fiber, and there are more fatty oil components. Both of these components can effectively promote gastrointestinal motility and can improve constipation.
- the laxative health care composition can effectively improve constipation, improve laxative effect, and improve skin.
- the embodiment of the present invention uses the Yuanzhi as a component of the laxative health care composition, and the dosage is 0.2 ⁇ 4 parts, specifically 0.2 parts, 0.5 parts, 1 part, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.3 parts, 3.5 parts, 4 parts.
- jujube kernels enter the liver meridian.
- the jujube kernel contains a large amount of fatty oil chemical components, which can effectively promote gastrointestinal peristalsis. But jujube kernels are acidic and have astringent effect, so they are not usually used as an active ingredient for laxatives.
- the jujube kernel is used in combination with licorice, wheat, jujube and Polygala can effectively improve the laxative effect of health tea.
- the jujube kernel is used as a component of the laxative health care composition, and the dosage is 0.3 ⁇ 5 parts, specifically, 0.3 parts, 0.5 parts, 0.8 parts, 1.0 parts, 1.2 parts, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 5 parts.
- licorice into the lung meridian
- wheat into the heart meridian
- jujube into the spleen meridian
- Yuanzhi into the kidney meridian
- sour jujube into the liver meridian
- the five are indispensable.
- the various raw materials (licorice, wheat, jujube, Polygala, sour jujube kernel) of the laxative health care composition have various interactions such as mutualism, beard, fear, or killing, only if they have the above effects
- the characteristic components can only be used for laxative, calming, calming, sleeping, and removing freckles when they are compatible according to the specific content of the embodiment of the present invention.
- the particle size of the licorice, wheat, jujube, Polygala, and jujube kernels is 50-200 mesh.
- the laxative health care composition composed of the above formula is packaged into 3-12 g per package.
- another aspect of the embodiments of the present invention provides a method for applying a laxative health care composition.
- a method for preparing laxative health tea includes the following steps:
- the treatment raw material is weighed according to the formula of the laxative health care composition of the present invention, and the treatment raw material is mixed and sterilized to obtain a laxative health care composition.
- the preparation method of the laxative health tea provided by the embodiment of the invention does not require deep processing, so the preparation process is simple, easy to produce, and the cost is low.
- the raw materials licorice, wheat, jujube, Polygala and sour jujube kernels should select better species, and be selected to remove inferior and inferior products.
- the impurities of the licorice, wheat, jujube, Yuanzhi and jujube kernels are removed to avoid the introduced impurities from affecting the quality of the laxative health care composition, especially its efficacy.
- step S02 the licorice, wheat, jujube, polygala, and jujube kernels are cut or cut or crushed into granules, so as to better exert their functions in subsequent use.
- the cutting, cutting or crushing should make the particles as small as possible, but will not be suspended in the soaking solution and affect the taste.
- the granular particle size is 50-200 mesh (74nm-335nm).
- the licorice, wheat, jujube, Polygala, and jujube kernels that have been cut or trimmed or crushed into granules are weighed according to the formula of the laxative health care composition, that is, the processing raw materials are processed. Mix and sterilize to obtain the laxative health care composition.
- the laxative health care composition is weighed and packaged according to the specification of 3 g to 12 g per package to prepare laxative health tea.
- a method for preparing a laxative health tablet includes the following steps:
- E02. Cut, cut or pulverize the licorice, wheat, jujube, polygala, and jujube kernels into 50-200 mesh granules respectively to obtain processing raw materials; E02.
- the laxative health care composition according to the present invention weighs the processed raw materials, mixes the processed raw materials uniformly, and after sterilization, directly compresses into tablets to obtain laxative health tablets.
- the raw materials licorice, wheat, jujube, Yuanzhi and jujube kernels should select better species, and be selected to remove inferior and inferior products.
- the impurities of the licorice, wheat, jujube, Yuanzhi and jujube kernels are removed to avoid the introduced impurities from affecting the quality of the laxative health care composition, especially its efficacy.
- the licorice, wheat, jujube, Polygala, and jujube kernels are cut or cut or crushed into granules, so as to better exert their functions in subsequent use.
- the cutting, cutting or crushing should make the particles as small as possible.
- the granular particle size is 50-200 mesh (74nm-335nm).
- step E03 according to the laxative health care composition of the present invention, the treatment raw materials are weighed, the treatment raw materials are mixed uniformly, after sterilization treatment, directly compressed into tablets, to obtain laxative health tablets.
- the mixed raw materials are compressed into tablets according to the specification of 2 g-6 g per tablet, and packaged to prepare laxative health tablets.
- a method for preparing a laxative health tablet includes the following steps:
- the laxative health-care composition of the present invention weigh licorice, wheat, jujube, polygala, and jujube kernels, mix the raw material components uniformly, add 130 ⁇ 170 parts of water, and soak for 15-60 min, decoction the immersion liquid for 20-40min to concentrate the decoction liquid to 60-80 parts, and filter to obtain filter residue A and filtrate A;
- the raw materials licorice, wheat, jujube, Polygala and sour jujube kernels should be selected from better species, and the inferior and inferior products should be selected through selection.
- the impurities of the licorice, wheat, jujube, Yuanzhi and jujube kernels are removed to avoid the introduced impurities from affecting the quality of the laxative health care composition, especially its efficacy.
- the licorice, wheat, jujube, Yuanzhi, and jujube kernels are cut or cut or crushed into granules to facilitate more efficient extraction of licorice, wheat, jujube, Yuanzhi, Water-soluble ingredients in Sour Dates.
- the cutting, cutting or crushing should make the particles as small as possible.
- the granularity is 50 ⁇ 200 mesh (74nm ⁇ 335nm)
- the treatment raw material is weighed, and 130-170 parts of water is added for soaking for 15-60 minutes, further, soaking for 15 minutes to extract water-soluble components; the soaking solution is decoction for 20-40 minutes, Particularly preferred is simmering for 30 minutes.
- the decoction liquid is subjected to solid-liquid separation, and the filter residue A and the filtrate A are collected respectively.
- step D02 add 130 ⁇ 170 parts of water to the filter residue A, soak again for 15-60min, and cook the soaking solution for 20-40min to concentrate the decoction to 60 ⁇ 80 parts, filter the treatment, and collect the filtrate B .
- 130-170 parts of water are continuously added to the filter residue A, and after soaking again for 15 minutes, the soaking liquid is simmered for 30 minutes to concentrate the decoction liquid to 60-80 parts, filtered, and the filtrate B is collected.
- the active ingredients in the licorice, wheat, jujube, Polygala, and jujube kernels are fully extracted by controlling the amount of water and the soaking time of the two soaking treatments, thereby giving the excellent laxative health care effect.
- the filtrate A and the filtrate B are mixed uniformly to obtain a laxative health oral solution.
- the embodiments of the present invention also provide the application of the laxative health care composition.
- a laxative health care tea is obtained from the laxative health care composition prepared by the method of the present invention, and is packaged and processed according to the specification of 3 g to 12 g per package.
- Laxative health tea can be used as a daily drink. It is simple, convenient and fast to take, satisfying the fast-paced life of modern people, especially young people, and can provide more choices of dosage forms and taking routes.
- a laxative health care oral liquid which is obtained by dividing the oral liquid prepared by the method of the present invention into separate packages.
- the laxative health oral liquid is simple, convenient and fast to take, meets the fast-paced life of modern people, especially young people, and can provide more choices of dosage forms and taking routes.
- a laxative health-care tablet The laxative health-care oral liquid is obtained by pressing and packaging the laxative health-care tablet according to the specification of 2g-6g per tablet.
- the laxative health care film uniform is simple, convenient and fast, meets the fast-paced life of modern people, especially young people, and can provide more choices of dosage forms and administration routes.
- a laxative health tea prepared by the following method:
- a laxative health care tablet prepared by the following method:
- a laxative health tea prepared by the following method:
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种通便保健组合物,由如下重量份数的下列组分组成:甘草0.2~5份、小麦1~10份、大枣1~11份、远志0.2~4份,酸枣仁0.3~5份。该组合物具有通便、养心安神、抗疲劳、增加记忆力、助睡眠、美容祛脂的功效,原料无需深层次加工,浸泡使用即可。此外,该组合物采用常见的中药成分作为原料,能够在保证功效的前提下,有效降低成本。
Description
本发明属于保健茶技术领域,尤其涉及一种通便保健组合物及其制备方法,以及含有上述通便保健组合物的通便保健茶、通便保健口服液和通便保健片剂。
饮茶文化在我国已有几千年的历史,通过饮茶达到舒缓紧张、预防保健的目的由来已久。《唐木章》中记载,“茗,苦茶,茶味甘苦,微寒无毒,一主瘘疮,利小便,去痰,解渴,令人少睡”。
现代社会生活节奏快,工作压力大,很多人身体处于亚健康状态。亚健康人最容易患的就是肠胃不适、便秘、肥胖、失眠、三高、心脑血管病和免疫力低下。便秘是临床常见的复杂症状,通常表现为:便意少,便次也少;排便艰难、费力;排便不畅;大便干结、硬便,排便不净感。长期便秘可伴腹胀,腹痛,大便带血等症状,容易诱发心、脑血管疾病的发作、诱发严重痔疮、肛裂、脱肛等疾病。在日常生活中服用药物自然是减轻症状的一种方式,目前治疗便秘的药物种类繁多。但是药物多数情况下有依赖性和副作用,长期服用对身体无益。因此,中药茶养生及治疗相关疾病被人们日益重视,养生茶也愈来愈成为亚健康人群首选的养生调理保健品。目前,中国的养生茶处于起步阶段,所占市场份额较小,虽然市场发展空间很大,但市场发展需要一个过程。养生茶的质量存在良莠不齐的现象,产品功能、功效达不到要求,以次充好大行其道。
本发明实施例提供了一种通便保健组合物及其制备方法、通便保健茶、通便保健口服液、通便保健片剂,旨在解决现有的现有保健茶产品功能不明确、功效达不到要求的问题。
为实现上述发明目的,本发明采用的技术方案如下:
一种通便保健组合物,由如下重量份数的下列组分组成:
甘草 0.2~5份;
小麦 1~10份;
大枣 1~11份;
远志 0.2~4份,
酸枣仁 0.3~5份。
一种通便保健茶的制备方法,包括以下步骤:
提供原料甘草、小麦、大枣、远志和酸枣仁;
分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成50~200目的颗粒状,获得处理原料;
按照本发明所述的通便保健组合物的配方称取所述处理原料,将所述处理原料进行混合、杀菌处理,获得通便保健组合物。
一种通便保健片的制备方法,包括以下步骤:
提供原料甘草、小麦、大枣、远志和酸枣仁;
分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成50~200目的颗粒状,获得处理原料;
按照本发明所述的通便保健组合物称取所述处理原料,将所述处理原料混合均匀,杀菌处理后,直接压制成片,获得通便保健片。
一种通便保健口服液的制备方法,包括以下步骤:
按照本发明所述的通便保健组合物称取甘草、小麦、大枣、远志、酸枣仁,将个原料组分混合均匀,加入130~170份水,浸泡15-60
min,将浸泡液煎煮20-40min使煎煮液浓缩至60~80份,过滤处理,分别得到滤渣A和滤液A;
向所述滤渣A中继续加入130~170份水,将浸泡液煎煮20-40min使煎煮液浓缩至60~80份,过滤处理,收集滤液B;
将滤液A与滤液B混合均匀,得到通便保健口服液。
对应的,一种通便保健茶,所述通便保健口服液由本发明方法制备的通便保健组合物,按3g ~ 12g每包规格包装处理获得。
一种通便保健口服液,所述通便保健口服液由本发明方法制备得到的口服液分装获得。
一种通便保健片,所述通便保健口服液由本发明所述通便保健片的制备方法按2g-6g每片的规格压制后包装出来获得。
本发明提供的通便保健组合物,由特定的配方组成,通过合理配制,充分发挥了当中各组分的协效作用,具有通便、养心安神、抗疲劳、增加记忆力、助睡眠、美容祛脂的功效。同时,所述通便保健组合物的原料无需深层次加工,浸泡使用即可,简单方便。此外,所述通便保健组合物采用常见的中药成分作为组成原料,不需要添加昂贵的中药组分或者添加剂,能够在保证上述功能的前提下,有效降低通便保健组合物的成本。
本发明提供的通便保健茶的制备方法,无需深层次加工,因此制备工艺简单,易于生产,成本低廉。
本发明提供的通便保健口服液的制备方法,将所述通便保健组合物分次采用特定含量的水进行浸泡后,将滤液合并获得,无需深层次加工,因此制备工艺简单,易于生产,成本低廉。
本发明提供的通便保健口服液的制备方法,将所述通便保健组合物混合后压制处理获得,无需深层次加工,因此制备工艺简单,易于生产,成本低廉。
将本发明所述通便保健组合物制成通便保健茶、通便保健口服液和通便保健片剂后,能够更方便使用者服用,提高了使用便捷性。
为了使本发明要解决的技术问题、技术方案及有益效果更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
在本发明的描述中,需要理解的是,术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性或者隐含指明所指示的技术特征的数量。由此,限定有“第一”、“第二”的特征可以明示或者隐含地包括一个或者更多个该特征。在本发明的描述中,“多个”的含义是两个或两个以上,除非另有明确具体的限定。
本发明实施例一方面提供了一种通便保健组合物,由如下重量份数的下列组分组成:
甘草 0.2~5份;
小麦 1~10份;
大枣 1~11份;
远志 0.2~4份,
酸枣仁 0.3~5份。
本发明实施例提供的通便保健组合物,由特定的配方组成,通过合理配制,充分发挥了当中各组分的协效作用,具有通便、养心安神、抗疲劳、增加记忆力、助睡眠、美容祛脂的功效。同时,所述通便保健组合物的原料无需深层次加工,浸泡使用即可,简单方便。此外,所述通便保健组合物采用常见的中药成分作为组成原料,不需要添加昂贵的中药组分或者添加剂,能够在保证上述功能的前提下,有效降低通便保健组合物的成本。
作为一种优选实施例,所述通便保健组合物,由如下重量份数的下列组分组成:
甘草 1~3份;
小麦 4~7份;
大枣 4~8份;
远志 0.5~2份,
酸枣仁 0.8~3份。
具体的,本发明实施例中,甘草入肺经。所述甘草含有多种活性成分,具有清热解毒,益气补脾,祛痰止咳,滋咳润肺,缓急止疼,调和诸药的作用。此外,甘草可以发挥环节脾胃虚弱,心悸气短,倦怠无力,痈肿疮毒,以及脾胃气虚,倦怠乏力等效果。发明实施例将所述甘草作为通便保健组合物的组分,可以抑制组胺引起的胃酸分泌过多,并具有抗酸和缓解胃肠平滑肌痉挛作用。本发明实施例将所述甘草作为通便保健组合物的组分,用量为0.2~5份,具体可为0.2份,0.5份,0.8份,1.0份,2.0份,3.5份,4.0份,5.0份。
本发明实施例中,小麦入心经。所述小麦营养丰富,含有淀粉、蛋白质、糖类、脂肪、卵磷脂、精氨酸、麦芽糖、蛋白酶、维生素等多种成分,不仅可以给机体提供热能,还可以增加细胞活力,调整胃肠功能,改善脑细胞功能,抗衰老,预防心脑血管疾病。小麦作为本发明实施例所述通便保健组合物的中药组分,可以改善便秘患者的通便。本发明实施例将所述甘草作为通便保健组合物的组分,用量为1~10份,具体可为1份,2.5份,4份,4.5份,6份,6.5份,8份,9份,10份。
本发明实施例中,大枣入脾经。大枣具有健脾和胃、补中益气、养血安神的功效,可用于脾虚食少,脾胃虚弱、乏力便溏,倦怠无力、气血不足、失眠、妇人脏躁。大枣的膳食纤维含量高,主要集中在皮中,可以有效的促进肠胃的蠕动,可以改善便秘患者的通便。此外,大枣中含有丰富的维生素C和环磷酸腺苷,能够促进肌肤细胞的代谢,防止黑色素沉着,让肌肤越来越洁白细滑,达到美白肌肤、祛斑的美容护肤功效。大枣具有预防输血反应,降低血清谷丙转氨酶,以及一定程度的抗肿瘤,抗氧化,降血压、降胆固醇,护肝,提高免疫力等作用,可用于防治脑供血不足,抗过敏,防治心血管病,防治骨质疏松和贫血。本发明实施例将所述大枣作为通便保健组合物的组分,用量为4 ~ 8份,具体可为1份,3份,3.3份,4份,5份,5.5份,6份,7.5份,8份,10份,11份。
本发明实施例中,远志入肾经。所述远志中含有比较多的膳食纤维,而且脂肪油的成分也比较多,这两种成分都能够有效的促进肠胃的蠕动,可以改善便秘现象。本发明实施例中,在通便保健组合物中可以有效改善便秘,提高通便作用,改善皮肤。本发明实施例将所述远志作为通便保健组合物的组分,用量为0.2 ~
4份,具体可为0.2份,0.5份,1份,1.5份,2份,2.5份,3份,3.3份,3.5份,4份。
本发明实施例中,酸枣仁入肝经。所述酸枣仁中含多量脂肪油化学成分,能够有效的促进肠胃的蠕动。但由于酸枣仁呈酸性,有收涩的作用,因此,通常不作为通便的活性成分。本发明实施例将所述酸枣仁与甘草、小麦、大枣、远志配伍使用,可以有效提高保健茶的通便功效。本发明实施例将所述酸枣仁作为通便保健组合物的组分,用量为0.3 ~
5份,具体可为0.3份,0.5份,0.8份,1.0份,1.2份,1.5份,2份,2.5份,3份,3.5份,4份,5份。
在本发明实施例提供的通便保健组合物,甘草(入肺经)、小麦(入心经)、大枣(入脾经)、远志(入肾经)、酸枣仁(入肝经),五种药食同源的物品,分别对应肺、心、脾、肾、肝,调理五脏六腑,协同起到通便、助眠的效果,五者缺一不可。
由于所述通便保健组合物的各原料(甘草、小麦、大枣、远志、酸枣仁)之间存在相生、相须、相畏或者相杀等多种相互作用的关系,只有当具有上述功效以及特点的各成分按照本发明实施例特定含量配伍时,才能使其具有通便、宁神安神、助睡眠、美容祛斑的作用。
在上述实施例的基础上,所述甘草、小麦、大枣、远志、酸枣仁的粒度为50~200目。
本发明实施例中,上述配方组成的所述通便保健组合物,所述通便保健组合物包装成 3~ 12g每包。
相应的,本发明实施例另一方面提供了通便保健组合物的应用方法。
作为一种实施方式,一种通便保健茶的制备方法,包括以下步骤:
S01.提供原料甘草、小麦、大枣、远志和酸枣仁;
S02.分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成50~200目的颗粒状,获得处理原料;
S03.按照本发明所述的通便保健组合物的配方称取所述处理原料,将所述处理原料进行混合、杀菌处理,获得通便保健组合物。
本发明实施例提供的通便保健茶的制备方法,无需深层次加工,因此制备工艺简单,易于生产,成本低廉。
具体的,上述步骤S01中,所述原料甘草、小麦、大枣、远志和酸枣仁应当选择较好物种,并经精选去除残次劣品。将所述甘草、小麦、大枣、远志和酸枣仁除去杂质,以避免引入的杂质影响通便保健组合物的质量,特别是影响其功效。
述步骤S02中,将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成颗粒状,为了在后续使用中能够更好的发挥其作用。所述切割或裁剪或粉碎,应使得颗粒尽可能的小,但又不会悬浮于浸泡液中影响口感为基准。具体的,所述颗粒状的粒度为50~200目(74nm~335nm)。
述步骤S03中,按照所述通便保健组合物的配方称取经切割或裁剪或粉碎成颗粒状的甘草、小麦、大枣、远志、酸枣仁,即所述处理原料,将所述处理原料进行混合、杀菌处理,获得所述通便保健组合物。
进一步的,在一些实施例中,称取所述通便保健组合物,按3g ~ 12g每包的规格进行包装处理,制备通便保健茶。
作为一种实施方式,一种通便保健片的制备方法,包括以下步骤:
E01.提供原料甘草、小麦、大枣、远志和酸枣仁;
E02.分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成50~200目的颗粒状,获得处理原料;
E03.按照本发明所述的通便保健组合物称取所述处理原料,将所述处理原料混合均匀,杀菌处理后,直接压制成片,获得通便保健片。
具体的,上述步骤E01中,所述原料甘草、小麦、大枣、远志和酸枣仁应当选择较好物种,并经精选去除残次劣品。将所述甘草、小麦、大枣、远志和酸枣仁除去杂质,以避免引入的杂质影响通便保健组合物的质量,特别是影响其功效。
述步骤E02中,将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成颗粒状,为了在后续使用中能够更好的发挥其作用。所述切割或裁剪或粉碎,应使得颗粒尽可能的小。具体的,所述颗粒状的粒度为50~200目(74nm~335nm)。
述步骤E03中,按照本发明所述的通便保健组合物称取所述处理原料,将所述处理原料混合均匀,杀菌处理后,直接压制成片,获得通便保健片.
进一步的,在一些实施例中,按2g-6g每片的规格将混合原料压制成片,包装处理,制备通便保健片。
作为一种实施方式,一种通便保健片的制备方法,包括以下步骤:
D01.按照本发明所述的通便保健组合物称取甘草、小麦、大枣、远志、酸枣仁,将个原料组分混合均匀,加入130~170份水,浸泡15-60
min,将浸泡液煎煮20-40min使煎煮液浓缩至60~80份,过滤处理,分别得到滤渣A和滤液A;
D02.向所述滤渣A中继续加入130~170份水,将浸泡液煎煮20-40min使煎煮液浓缩至60~80份,过滤处理,收集滤液B;
D03.将滤液A与滤液B混合均匀,得到通便保健口服液。
具体的,上述步骤D01中,所述原料甘草、小麦、大枣、远志和酸枣仁应当选择较好物种,并经精选去除残次劣品。将所述甘草、小麦、大枣、远志和酸枣仁除去杂质,以避免引入的杂质影响通便保健组合物的质量,特别是影响其功效。优选的,在浸泡处理之前,将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成颗粒状,以方便在浸泡过程中更高效地提取甘草、小麦、大枣、远志、酸枣仁中的水溶性成分。所述切割或裁剪或粉碎,应使得颗粒尽可能的小。具体的,所述颗粒状的粒度为50~200目(74nm~335nm)
按照本发明所述的通便保健组合物称取所述处理原料,加入130~170份水进行浸泡15-60min,进一步的,浸泡15min,提取水溶性成分;将浸泡液煎煮20-40min,特别优选文火煎煮30min。将煎煮液进行固液分离,分别收集滤渣A和滤液A。
述步骤D02中,向所述滤渣A中继续加入130~170份水,再次浸泡15-60min,将浸泡液煎煮20-40min使煎煮液浓缩至60~80份,过滤处理,收集滤液B。进一步优选的,向所述滤渣A中继续加入130~170份水,再次浸泡15min后,将浸泡液文火煎煮30min使煎煮液浓缩至60~80份,过滤处理,收集滤液B。
通过控制两次浸泡处理的水量和浸泡时间,将所述甘草、小麦、大枣、远志、酸枣仁中的活性成分充分提取出来,从而赋予所述优异的通便保健功效。
述步骤D03中,将滤液A与滤液B混合均匀,得到通便保健口服液。
相应的,本发明实施例还提供了通便保健组合物的应用。具体的,
一种通便保健茶,所述通便保健口服液由本发明方法制备的通便保健组合物,按3g ~ 12g每包规格包装处理获得。通便保健茶可以作为日常饮品,服用简单、方便、快捷,满足现代人,尤其是年轻人的快节奏的生活,且可以提供更多的选择剂型及服用途径。
一种通便保健口服液,所述通便保健口服液由本发明方法制备得到的口服液分装获得。所述通便保健口服液服用简单、方便、快捷,满足现代人,尤其是年轻人的快节奏的生活,且可以提供更多的选择剂型及服用途径。
一种通便保健片,所述通便保健口服液由本发明所述通便保健片的制备方法按2g-6g每片的规格压制后包装出来获得。所述通便保健片制服用简单、方便、快捷,满足现代人,尤其是年轻人的快节奏的生活,且可以提供更多的选择剂型及服用途径。
下面结合具体实施例进行说明。
实施例1
一种通便保健茶,所述通便保健茶通过下述方法制备获得:
选取原料甘草、小麦、大枣、远志、酸枣仁;
分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成颗粒;
将经切割或裁剪或粉碎后的甘草1份、小麦4份、大枣 4份、远志 1.5 份,与酸枣仁0.5份混合后,进行杀菌处理,获得通便保健茶。
实施例 2
一种通便保健片,所述通便保健片通过下述方法制备获得:
选取原料甘草、小麦、大枣、远志、酸枣仁;
分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成颗粒;
将经切割或裁剪或粉碎后的甘草0.5份、小麦5份、大枣 3份、远志 1.0份,与酸枣仁1.5份混合后,进行杀菌处理,直接压片后,获得通便保健片。
实施例 3
一种通便保健茶,所述通便保健茶通过下述方法制备获得:
选取原料甘草、小麦、大枣、远志、酸枣仁;
分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成颗粒;
将经切割或裁剪或粉碎后的甘草1.5份、小麦3份、大枣5份、远志2份,与酸枣仁1.2份混合后,加入130份水,浸泡15min,文火进行煎煮30min;过滤得到滤液A和滤渣 A,得到65份滤液A。向滤渣A中继续加入130份水,文火进行煎煮30min;过滤得到65份滤液B;将滤液A与滤液B混合均匀,获得通便保健口服液。
实施例 4
选择30位便秘的成年人和老年人试用,每人每天饮用实施例1中所制备的通便保健茶 10g,连续饮用一个月,有 27人,排便的次数明显的增加,大便的干燥硬结程度也有明显的改善,其中的20人,原来3或4天才有排便的,经过饮用通便保健茶后,基本上1或2天都有排便,便秘情况明显改善,而且饮用后均无毒副作用。
实施例 5
选择20位睡眠不好、多梦的成年人和老年人试用,每人每天饮用实施例2中所制备的通便保健片剂12g,连续饮用一个月,有12人睡眠质量提高,而且饮用后均无毒副作用。
实施例6
选择 20 位工作压力大,亚健康的成年人试用,每人每天饮用实施例3中所制备的通便保健口服液130g,连续饮用半年,有 16 人反映身体状况有明显改善,精神与往常相比较好,而且饮用后均无毒副作用。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (10)
- 一种通便保健组合物,其特征在于,由如下重量份数的下列组分组成:甘草 0.2~5份;小麦 1~10份;大枣 1~11份;远志 0.2~4份,酸枣仁 0.3~5份。
- 如权利要求1所述的通便保健组合物,其特征在于,由如下重量份数的下列组分组成:甘草 1~3份;小麦 4~7份;大枣 4~8份;远志 0.5~2份,酸枣仁 0.8~3份。
- 如权利要求1或2所述的通便保健组合物,其特征在于,所述甘草、小麦、大枣、远志、酸枣仁的粒度为50~200目。
- 一种通便保健茶的制备方法,其特征在于,包括以下步骤:提供原料甘草、小麦、大枣、远志和酸枣仁;分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成50~200目的颗粒状,获得处理原料;按照权利要求1-2任一项所述的通便保健组合物的配方称取所述处理原料,将所述处理原料进行混合、杀菌处理,获得通便保健组合物。
- 如权利要求4所述的通便保健茶的制备方法,其特征在于,称取所述通便保健组合物,按3g ~ 12g每包的规格进行包装处理,制备通便保健茶。
- 一种通便保健片的制备方法,其特征在于,包括以下步骤:提供原料甘草、小麦、大枣、远志和酸枣仁;分别将所述甘草、小麦、大枣、远志、酸枣仁切割或裁剪或粉碎成50~200目的颗粒状,获得处理原料;按照权利要求1-2任一项所述的通便保健组合物称取所述处理原料,将所述处理原料混合均匀,杀菌处理后,直接压制成片,获得通便保健片。
- 一种通便保健口服液的制备方法,其特征在于,包括以下步骤:按照权利要求1-2任一项所述的通便保健组合物称取甘草、小麦、大枣、远志、酸枣仁,将个原料组分混合均匀,加入130~170份水,浸泡15-60 min,将浸泡液煎煮20-40min使煎煮液浓缩至60~80份,过滤处理,分别得到滤渣A和滤液A;向所述滤渣A中继续加入130~170份水,将浸泡液煎煮20-40min使煎煮液浓缩至60~80份,过滤处理,收集滤液B;将滤液A与滤液B混合均匀,得到通便保健口服液。
- 一种通便保健茶,其特征在于,所述通便保健口服液由上述权利要求4所述方法制备的通便保健组合物,按3g ~ 12g每包规格包装处理获得。
- 一种通便保健口服液,其特征在于,所述通便保健口服液由上述权利要求6所述方法制备得到的口服液分装获得。
- 一种通便保健片,其特征在于,所述通便保健口服液由上述权利要求7所述方法,按2g-6g每片的规格压制后包装出来获得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/112135 WO2020082345A1 (zh) | 2018-10-26 | 2018-10-26 | 通便保健组合物及其制备方法、通便保健茶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/112135 WO2020082345A1 (zh) | 2018-10-26 | 2018-10-26 | 通便保健组合物及其制备方法、通便保健茶 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020082345A1 true WO2020082345A1 (zh) | 2020-04-30 |
Family
ID=70330254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/112135 WO2020082345A1 (zh) | 2018-10-26 | 2018-10-26 | 通便保健组合物及其制备方法、通便保健茶 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2020082345A1 (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102048968A (zh) * | 2009-10-30 | 2011-05-11 | 赵春 | 一种大枣远志口服液的制备方法 |
CN103127401A (zh) * | 2011-11-25 | 2013-06-05 | 费佳 | 一种治疗神经衰弱的药物组合物及其制备方法 |
CN105031318A (zh) * | 2015-06-25 | 2015-11-11 | 威海御膳坊生物科技有限公司 | 一种改善睡眠的中药复方口服液制剂及制备方法 |
CN109170063A (zh) * | 2018-10-26 | 2019-01-11 | 卢文武 | 通便保健组合物及其制备方法、通便保健茶 |
-
2018
- 2018-10-26 WO PCT/CN2018/112135 patent/WO2020082345A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102048968A (zh) * | 2009-10-30 | 2011-05-11 | 赵春 | 一种大枣远志口服液的制备方法 |
CN103127401A (zh) * | 2011-11-25 | 2013-06-05 | 费佳 | 一种治疗神经衰弱的药物组合物及其制备方法 |
CN105031318A (zh) * | 2015-06-25 | 2015-11-11 | 威海御膳坊生物科技有限公司 | 一种改善睡眠的中药复方口服液制剂及制备方法 |
CN109170063A (zh) * | 2018-10-26 | 2019-01-11 | 卢文武 | 通便保健组合物及其制备方法、通便保健茶 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178884B (zh) | 用于气虚体质人调节脾胃虚弱的中药制剂及其制备方法和应用 | |
CN101966271B (zh) | 一种治疗高血压的中药汤剂 | |
CN102178912B (zh) | 用于阳虚体质的人缓解胃脘冷痛症状的中药制剂及其制备方法和应用 | |
CN105749179A (zh) | 治疗代谢综合征的中药组合物 | |
CN102512615B (zh) | 一种用于癌症恢复期的中药组合物 | |
CN106509576A (zh) | 一种具有促进消化功效的粉末冲剂及其制备方法 | |
CN106490558A (zh) | 一种保健蜂蜜及其制备方法 | |
CN106214916A (zh) | 一种用于治疗围绝经期综合征的药物及其制备方法 | |
CN101912523A (zh) | 一种治疗小儿缺铁性贫血症的中药制剂 | |
CN105343865A (zh) | 一种治疗神经性呕吐的药物及其制备方法 | |
CN104398788A (zh) | 一种治疗失眠的中药冲剂及其制备方法 | |
CN102526537A (zh) | 一种治疗高血糖的药物组合物 | |
WO2020082345A1 (zh) | 通便保健组合物及其制备方法、通便保健茶 | |
CN103830649B (zh) | 一种治疗慢性酒精中毒的药物及其制备方法 | |
CN109170063A (zh) | 通便保健组合物及其制备方法、通便保健茶 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 | |
CN107362301A (zh) | 香苓开胃颗粒 | |
CN108434278A (zh) | 安神定志汤 | |
CN106361982A (zh) | 一种治疗糖尿病的药食两用中药制剂及其制备方法 | |
CN105456951A (zh) | 一种治疗乳房纤维腺瘤的中药制剂及其制备方法 | |
CN117442694A (zh) | 一种药食同源养胎中药复方及其制备方法 | |
CN105125694A (zh) | 一种快速降压膏及其制作方法 | |
CN104825879A (zh) | 临床护理用健脾补肾胶囊及制备方法 | |
CN113749240A (zh) | 一种助眠葱白水及其制备工艺 | |
CN103638468B (zh) | 一种治疗蚕豆病的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18938195 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18938195 Country of ref document: EP Kind code of ref document: A1 |